ArticleBMJ open2022

Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.

Elaine Butterly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.